Apogee Therapeutics, Inc.
APGE
$68.50
$1.732.59%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 730.19M | 527.29M | 505.42M | 513.33M | 520.65M |
| Total Receivables | 5.96M | 4.48M | 4.14M | 5.01M | 4.70M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.60M | 7.41M | 5.60M | 2.61M | 2.62M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 605.00K | 919.00K | 963.00K | 586.00K | 1.74M |
| Total Current Assets | 741.36M | 540.10M | 516.12M | 521.53M | 529.71M |
|
|
|||||
| Total Current Assets | 741.36M | 540.10M | 516.12M | 521.53M | 529.71M |
| Net Property, Plant & Equipment | 14.38M | 15.68M | 17.02M | 17.19M | 13.32M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.67M | 8.74M | 8.86M | 7.34M | 498.00K |
| Total Assets | 937.13M | 626.16M | 657.77M | 714.16M | 753.95M |
|
|
|||||
| Total Accounts Payable | 1.22M | 376.00K | 5.68M | 2.45M | 1.07M |
| Total Accrued Expenses | 23.18M | 29.59M | 21.85M | 26.54M | 24.26M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.50M | 4.08M | 4.03M | 3.98M | 3.23M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 27.91M | 34.05M | 31.55M | 32.96M | 28.56M |
|
|
|||||
| Total Current Liabilities | 27.91M | 34.05M | 31.55M | 32.96M | 28.56M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.35M | 5.77M | 6.82M | 7.84M | 8.60M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 33.25M | 39.82M | 38.37M | 40.80M | 37.16M |
|
|
|||||
| Common Stock & APIC | 1.46B | 1.08B | 1.05B | 1.03B | 1.02B |
| Retained Earnings | -561.76M | -492.37M | -427.35M | -361.26M | -305.92M |
| Treasury Stock & Other | 1.08M | 1.03M | 685.00K | 1.07M | 915.00K |
| Total Common Equity | 903.88M | 586.34M | 619.40M | 673.36M | 716.79M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 903.88M | 586.34M | 619.40M | 673.36M | 716.79M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 903.88M | 586.34M | 619.40M | 673.36M | 716.79M |
|
|
|||||